InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Taylor Stacy L, Vice-Président. Officer active across 1 company, notably Adaptive Biotechnologies Corp. Aggregated, 10 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €134k. History available since 30 April 2021. The latest transaction was filed on 22 August 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Taylor Stacy L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
26,922 shares@ US$4.497436.6% of flowCommon StockSEC:0001062993-24-015606:0
39,990 shares0Common StockSEC:0001062993-24-005766:0
85,697 shares0Common StockSEC:0001062993-23-006328:0
2,387 shares@ US$11.440.0012% mcap13.3% of flowCommon StockSEC:0001209191-22-018095:0
61,779 shares0Common StockSEC:0001209191-22-017397:0
10,130 shares@ US$6.550.0029% mcap31.1% of flowCommon StockSEC:0001209191-21-071194:0
495 shares@ US$6.551.3% of flowCommon StockSEC:0001209191-21-055367:0
1,042 shares@ US$7.803.2% of flowCommon StockSEC:0001209191-21-044630:0
1,041 shares@ US$7.803.2% of flowCommon StockSEC:0001209191-21-042291:0
1,042 shares@ US$7.803.1% of flowCommon StockSEC:0001209191-21-029626:0
10 of 10 declarations
About Taylor Stacy L
Stacy L. Taylor is the Senior Vice President and General Counsel at Adaptive Biotechnologies Corp. She is responsible for the company's legal and compliance matters. Her expertise in business law and risk management enables her to contribute to the legal strategy and protect Adaptive's interests.
